Subscribe to RSS - BioScrip

BioScrip

BioScrip execs will continue at combined company

 - 
06/13/2019

DENVER – Key members of BioScrip’s leadership team will continue in executive roles with the combined company following the close of its pending merger with Option Care Enterprises.

In brief: KCI sells to 3M, senators introduce accessories bill

 - 
05/03/2019

SAN ANTONIO and NEW YORK – A consortium of funds led by Apax Partners has entered into a definitive agreement to sell Acelity and its KCI subsidiaries worldwide to 3M for about $6.725 billion.

BioScrip reports revenue growth

 - 
05/02/2019

DENVER – BioScrip reported revenues of $179 million for the first quarter of 2019, an increase of 6.2% over the first quarter of 2018. Net loss from continuing operations was $10.3 million vs. $13 million.

Q&A: Option Care's John Rademacher

 - 
04/29/2019

When the ink dries on the planned merger of two of the country’s leading home infusion services providers, it will form an organization that is deeply committed to patient care, says John Rademacher, CEO of the combined company of Option Care and BioScri

Option Care positions itself as ‘partner of choice’

 - 
03/22/2019

DENVER, Colo., and BANNOCKBURN, Ill. – Option Care CEO John Rademacher says its merger with BioScrip will create a “powerful, independent platform” in the growing $100 million infusion market.

In brief: BioScrip, Option Care to merge; Aeroflow launches CBD division

 - 
03/15/2019

DENVER – BioScrip and Option Care Enterprises, two of the largest independent providers of home infusion therapy services, have entered into a definitive merger agreement, the companies announced on March 15.

BioScrip, Option Care to merge

 - 
03/15/2019

DENVER – BioScrip and Option Care Enterprises, two of the largest independent providers of home infusion therapy services, have entered into a definitive merger agreement, the companies announced on March 15.

Earnings season: Inogen, BioScrip, VieMed

 - 
11/07/2018

GOLETA, Calif. – Inogen reported $95.3 million in total revenue for the third quarter of 2018, a 38% increase over the same period last year.

CMS finalizes temporary payment for infusion services

 - 
11/01/2018

WASHINGTON – CMS has finalized a rule that includes a temporarily transitional payment for home infusion services, and implements a new home infusion therapy benefit.

New leadership: Fisher & Paykel, BioScrip

 - 
10/23/2018

Fisher & Paykel Healthcare has appointed Lyndal York CFO. She will join the company in March 2019 and will report to CEO Lewis Gradon.

Pages